ad
  1. Home
  2. IPO
  3. Park Medi World
stock logo

Park Medi World

17 Dec '25MAINBOARD

Min. Investment

₹14,168

Issue size

920 Cr

GMP

Locked

Overall subscription: 8x

Check allotment status
Locked Content
About company
IPO dates

10 Dec

Opening

12 Dec

Closing

15 Dec

Allotment

17 Dec

Listing

*Refunds will be initiated on 16 Dec '25

About company

IPO quota

ApplicationLotsSharesAmount
Retail (Min)192₹14,904
HNI (Min)141288₹2,08,656
ad
About company

Subscription (as on 27 December 2025, 08:30 AM)

Overall8x
QIB IconQualified institutional buyers
11.48x
NIB IconNon-Institutional Buyers
15.07x
Retail IconRetail Investors
2.98x
Employee IconEmployee
-
About company

About company

Founded: 2011|MD: Dr Ankit Gupta
  • The company operates a network of private hospitals in North India with a total bed capacity of 3,000 beds as of September 30, 2024. It is reported to be the largest private hospital chain in Haryana by bed capacity, with 1,600 beds located throughout the state. The network consists of 13 hospitals under the “Park” brand, all of which are National Accreditation Board for Hospitals & Healthcare Providers (NABH) accredited, and seven are also National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited. These hospitals are located in Haryana, New Delhi, Punjab, and Rajasthan.
  • The company offers more than 30 medical specialities and super-specialities, including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology. As of September 30, 2024, the workforce included 891 doctors and 1,912 nurses.
  • The hospital network was initially developed through new establishments beginning in 2005 and has subsequently expanded through acquisitions in multiple locations.
  • Use of proceeds:
  • The IPO consists of both a fresh issue of shares and an offer for sale (OFS).​ Proceeds from the OFS will go to the respective selling shareholders, whereas the net proceeds from the fresh issue will be utilised for the following purposes:​
  • Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the company and certain of the subsidiaries — Rs 410 crore
  • Funding capital expenditure for the development of a new hospital and expansion of the existing hospital by certain subsidiaries, Park Medicity (NCR) and Blue Heavens, respectively — Rs 110 crore
  • Funding capital expenditure for the purchase of medical equipment by the company and certain subsidiaries, Blue Heavens and Ratangiri — Rs 77.19 crore
  • Unidentified inorganic acquisitions and general corporate purposes
About company

Issue Details & Objective

Fresh issue

Lot size

92 Shares

Price band

154 to 162

Face value

₹2 per share

ad
About company
Financials
Revenue
Value in Cr.
Profit
Value in Cr.
Total assets
Value in Cr.
About company
IPO reservation

Anchor investor - 30.00%

QIB - 20.00%

Retail - 35.00%

FAQs

Should I apply for the Park Medi World IPO?

arrow
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.

What is the issue size of Park Medi World IPO?

arrow
The issue size of Park Medi World IPO is ₹920 Cr

What are the open and close dates for Park Medi World IPO?

arrow
The Park Medi World IPO will be open for applications from 10 Dec '25 to 12 Dec '25

What is the lot size and minimum order quantity of Park Medi World IPO?

arrow
The lot size of Park Medi World IPO is 92 Shares and its minimum investment amount is ₹14,168.

What is the GMP value of Park Medi World IPO?

arrow
Grey market premium (GMP) is a premium amount at which grey market IPO shares are traded before they get listed in the stock exchange. The GMP for Park Medi World IPO is 16.05
ad
icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
General
arrow down